IL-4 exerts immunomodulatory effects by inhibiting the production of pro-inflammatory cytokine IL-17 in the synovium of RA patients, indicating its anti-inflammatory function in the chronic inflammatory stage [34]. Here, IL17A is linked to rheumatoid arthritis.